Cytokeratin 8&18 (ABT053/CK18) mouse mAb

Alias:CARD2;CK 8;CK-8;CK8;CYK8;CYKER;Cytokeratin endo A;CytokeRatin-8;DreK8;EndoA;K2C8;K2C8_HUMAN;K8;KeRatin 8;KeRatin type II cytoskeletal 8;KeRatin, type II cytoskeletal 8;KeRatin-8;KO;Krt 2.8;KRT8;MGC118110;MGC174782;MGC53564;MGC85764;sb:cb186;Type-II keRatin Kb8;CK 18;CK-18;CK18;CYK18;Cytokeratin 18;Cytokeratin endo B;CytokeRatin-18;K 18;K18;K1C18_HUMAN;KA18;KeRatin 18;KeRatin 18, type I;KeRatin D;keRatin, type I cytoskeletal 18;KeRatin-18;Krt18

CatalogNo:HJRLM4798

Specifications

50μL;100μL

Delivery date

spot

Target

Cytokeratin 8/18

Reactivity

Human,Mouse,Rat,

Application - After Update

IHC,WB,IF,ELISA

MW(Observed)

48,54kD

Host Species

Mouse

Isotype

IgG2b,Kappa

Modify

Unmodified

Recommended dilution ratio

IHC 1:200-1000;WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000

compose

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Clonality

Monoclonal

Clone Number

ABT053/CK18

Immunogen

Synthesized peptide derived from human Cytokeratin 8&18 AA range: C-term to CK8 and 200-300 to CK18

Specificity

This product can specifically recognize human CK8 and CK18 protein. It is a cocktail of anti-CK8 and anti-CK18 monoclonal antibodies.

Gene name

KRT8/KRT18

Organism-1

Human